News

Inhibikase Therapeutics is advancing IKT-001, a prodrug of imatinib mesylate, toward a Phase 2b clinical trial for the treatment...

Annexon Biosciences’ recent corporate update reveals a company aggressively navigating the complex landscape of complement-mediated drug development, with a...

Camp4 Therapeutics, a clinical-stage biotech focused on RNA-targeting therapeutics, has released its Q2 2025 financial results alongside promising preclinical...

Macrogenics Charts a Course Toward Focused Growth and Enhanced Capital Efficiency Macrogenics, a clinical-stage biopharmaceutical company specializing in antibody-based...

Life Biosciences Forges Singapore Alliance to Advance Epigenetic Reprogramming for Age-Related Diseases Life Biosciences’ recent memorandum of understanding with...

Sanofi’s acquisition of ViceBio for an upfront payment of $1.15 billion, plus potential milestones, signifies a strategic move to...

Liminatus Pharma, a preclinical-stage biotech company, is exploring the integration of regulated digital assets into its treasury management strategy....

BioCardia and CART-Tech Partner to Advance Heart3D Fusion Imaging for Biotherapeutic Delivery BioCardia and CART-Tech have announced an exclusive...

Tilray’s FL Group Forges Strategic Partnership with Molteni to Expand Medical Cannabis Access in Italy Tilray Medical, through its...

POP Biotechnologies Secures CEPI Funding to Advance “Plug-and-Play” Vaccine Platform POP Biotechnologies has secured up to $1.5 million in...